Pune, India -- (SBWIRE) -- 10/24/2018 -- This study researches the market size of Antifungal Drugs in United States, European Union and China, presents the Antifungal Drugs sales, revenue, market share and growth rate by companies, type and application, history breakdown data from 2013 to 2018, and forecast to 2025.

For top companies in United States, European Union and China, this report investigates and analyzes the sales, revenue, market share and growth rate for the top players, key data from 2013 to 2018.

An antifungal drug, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis (thrush), serious systemic infections such as cryptococcal meningitis, and others. Such drugs are usually obtained by a doctor's prescription, but a few are available OTC (over-the-counter).

Asia Pacific is expected to be the fastest growing regional segment for the antifungal drug market in 2017 within the forecast period due to the rapid spread of fungal infection in this region. Asia Pacific accounted as a leading market of the global antifungal drug market in 2015 in terms of growth.

PDF Sample For In-depth Analysis and Forecast - https://www.qyresearch.com/sample-form/form/836334/global-united-states-european-union-and-china-antifungal-drugs-market

In 2018, the market size of Antifungal Drugs is xx million US$ and it will reach xx million US in 2025, growing at a CAGR of xx% from 2018; while in China, the market size is valued at xx million US$ and will increase to xx million US in 2025, with a CAGR of xx% during forecast period.

In this report, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Antifungal Drugs.

In United States, European Union and China market, the following companies are covered:

Asperqillus

Alternaria

Abbott Laboratories

Pfizer

GlaxoSmithKline

Bayer Healthcare

Novartis

Sanofi-Aventis

Merck

Kramer Laboratories

Enzon Pharmaceuticals

Gilead

Market Segment by Product Type

Clotrimazole.

Econazole.

Miconazole.

Terbinafine.

Fluconazole.

Ketoconazole.

Amphotericin.

Market Segment by Application

Hospitals

Clinics

Key Regions split in this report:

United States

China

European Union

Rest of World (Japan, Korea, India and Southeast Asia)

Browse report Details with Complete ToC- https://www.qyresearch.com/index/detail/836334/global-united-states-european-union-and-china-antifungal-drugs-market

The study objectives are:

To analyze and research the Antifungal Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.

To present the key Antifungal Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.

To split the breakdown data by regions, type, companies and applications

To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.

To identify significant trends, drivers, influence factors in global and regions

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Antifungal Drugs are as follows:

History Year: 2013-2018

Base Year: 2017

Estimated Year: 2018

Forecast Year 2018 to 2025